404 related articles for article (PubMed ID: 26059772)
1. The Study of Carbamoyl Phosphate Synthetase 1 Deficiency Sheds Light on the Mechanism for Switching On/Off the Urea Cycle.
Díez-Fernández C; Gallego J; Häberle J; Cervera J; Rubio V
J Genet Genomics; 2015 May; 42(5):249-60. PubMed ID: 26059772
[TBL] [Abstract][Full Text] [Related]
2. Understanding carbamoyl phosphate synthetase (CPS1) deficiency by using the recombinantly purified human enzyme: effects of CPS1 mutations that concentrate in a central domain of unknown function.
Díez-Fernández C; Hu L; Cervera J; Häberle J; Rubio V
Mol Genet Metab; 2014 Jun; 112(2):123-32. PubMed ID: 24813853
[TBL] [Abstract][Full Text] [Related]
3. Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis.
Pekkala S; Martínez AI; Barcelona B; Yefimenko I; Finckh U; Rubio V; Cervera J
Hum Mutat; 2010 Jul; 31(7):801-8. PubMed ID: 20578160
[TBL] [Abstract][Full Text] [Related]
4. Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis.
de Cima S; Polo LM; Díez-Fernández C; Martínez AI; Cervera J; Fita I; Rubio V
Sci Rep; 2015 Nov; 5():16950. PubMed ID: 26592762
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool.
Diez-Fernandez C; Martínez AI; Pekkala S; Barcelona B; Pérez-Arellano I; Guadalajara AM; Summar M; Cervera J; Rubio V
Hum Mutat; 2013 Aug; 34(8):1149-59. PubMed ID: 23649895
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: characterization of a founder mutation by use of recombinant CPS1 from insect cells expression.
Hu L; Diez-Fernandez C; Rüfenacht V; Hismi BÖ; Ünal Ö; Soyucen E; Çoker M; Bayraktar BT; Gunduz M; Kiykim E; Olgac A; Pérez-Tur J; Rubio V; Häberle J
Mol Genet Metab; 2014 Dec; 113(4):267-73. PubMed ID: 25410056
[TBL] [Abstract][Full Text] [Related]
7. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency.
Martínez AI; Pérez-Arellano I; Pekkala S; Barcelona B; Cervera J
Mol Genet Metab; 2010 Dec; 101(4):311-23. PubMed ID: 20800523
[TBL] [Abstract][Full Text] [Related]
8. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
[TBL] [Abstract][Full Text] [Related]
9. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.
Diez-Fernandez C; Häberle J
Expert Opin Ther Targets; 2017 Apr; 21(4):391-399. PubMed ID: 28281899
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.
Shi D; Zhao G; Ah Mew N; Tuchman M
Mol Genet Metab; 2017 Mar; 120(3):198-206. PubMed ID: 28007335
[TBL] [Abstract][Full Text] [Related]
11. CPS1: Looking at an ancient enzyme in a modern light.
Nitzahn M; Lipshutz GS
Mol Genet Metab; 2020 Nov; 131(3):289-298. PubMed ID: 33317798
[TBL] [Abstract][Full Text] [Related]
12. Understanding carbamoyl phosphate synthetase deficiency: impact of clinical mutations on enzyme functionality.
Yefimenko I; Fresquet V; Marco-Marín C; Rubio V; Cervera J
J Mol Biol; 2005 May; 349(1):127-41. PubMed ID: 15876373
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
Zhang S; Hu Y; Wu Z; Zhou X; Wu T; Li P; Lian Q; Xu S; Gu J; Chen L; Wu G; Zhang T; Tang J; Xue J
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1244-1256. PubMed ID: 36423742
[TBL] [Abstract][Full Text] [Related]
14. Structural insight on the control of urea synthesis: identification of the binding site for N-acetyl-L-glutamate, the essential allosteric activator of mitochondrial carbamoyl phosphate synthetase.
Pekkala S; Martínez AI; Barcelona B; Gallego J; Bendala E; Yefimenko I; Rubio V; Cervera J
Biochem J; 2009 Nov; 424(2):211-20. PubMed ID: 19754428
[TBL] [Abstract][Full Text] [Related]
15. Variant in the allosteric domain of CPS1 protein associated with effectiveness of N-carbamoyl glutamate therapy in neonatal onset CPS1 deficiency.
Gragnaniello V; Gueraldi D; Puma A; Commone A; Loro C; Cazzorla C; Häberle J; Burlina AB
J Pediatr Endocrinol Metab; 2023 Sep; 36(9):873-878. PubMed ID: 37427576
[TBL] [Abstract][Full Text] [Related]
16. Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency.
Nitzahn M; Allegri G; Khoja S; Truong B; Makris G; Häberle J; Lipshutz GS
Mol Ther; 2020 Jul; 28(7):1717-1730. PubMed ID: 32359471
[TBL] [Abstract][Full Text] [Related]
17. Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy.
Chen X; Yuan L; Sun M; Liu Q; Wu Y
J Clin Lab Anal; 2018 Jun; 32(5):e22375. PubMed ID: 29314318
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases.
Zhang L; Zou Y; Lu Y; Li Z; Gao F
Bioorg Chem; 2023 Jan; 130():106253. PubMed ID: 36356370
[TBL] [Abstract][Full Text] [Related]
19. Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing.
Choi R; Park HD; Yang M; Ki CS; Lee SY; Kim JW; Song J; Chang YS; Park WS
Ann Lab Med; 2017 Jan; 37(1):58-62. PubMed ID: 27834067
[TBL] [Abstract][Full Text] [Related]
20. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
